After hacking Trivy, TeamPCP moved to compromise repositories across NPM, Docker Hub, VS Code, and PyPI, stealing over 300GB of data.

Threat actors abused trusted Trivy distribution channels to inject credential‑stealing malware into CI/CD pipelines worldwide. This analysis walks through the Trivy supply‑chain compromise, attacker ...

The TeamPCP hacking group continues its supply-chain rampage, now compromising the massively popular "LiteLLM" Python package on PyPI and claiming to have stolen data from hundreds of thousands of ...

In case you've faced some hurdles solving the clue, Simple machine with a fulcrum, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time ...

CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives ...

San Francisco, CA /PRNewswire/ - Fulcrum, the AI-powered field process management and data collection platform, today announced it has acquired Wildnote, an environmental software company focused on ...

SAN FRANCISCO--(BUSINESS WIRE)--Fulcrum, the leading AI platform for insurance brokerages, today announced $25 million in combined Seed and Series A funding led by CRV, with participation from South ...

Used by many of the top U.S. brokerages, Fulcrum’s AI platform cuts policy delivery from 15 days to same-day turnarounds and proposals down from eight hours to as little two Fulcrum, the leading AI ...

Earnings announcements are one of the few scheduled events that consistently move markets. Prices react not just to the reported numbers, but to how those numbers compare with expectations. A small ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Fulcrum Therapeutics (FULC) on Saturday reported positive initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease. “We are highly ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...